These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29073169)

  • 1. Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    Johannessen C; Moi L; Kiselev Y; Pedersen MI; Dalen SM; Braaten T; Busund LT
    PLoS One; 2017; 12(10):e0186658. PubMed ID: 29073169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
    Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
    J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
    Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
    Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.
    Rothé F; Ignatiadis M; Chaboteaux C; Haibe-Kains B; Kheddoumi N; Majjaj S; Badran B; Fayyad-Kazan H; Desmedt C; Harris AL; Piccart M; Sotiriou C
    PLoS One; 2011; 6(6):e20980. PubMed ID: 21738599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
    Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
    Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
    BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of miR-100 in regulating apoptosis of breast cancer cells.
    Gong Y; He T; Yang L; Yang G; Chen Y; Zhang X
    Sci Rep; 2015 Jul; 5():11650. PubMed ID: 26130569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
    Sempere LF; Christensen M; Silahtaroglu A; Bak M; Heath CV; Schwartz G; Wells W; Kauppinen S; Cole CN
    Cancer Res; 2007 Dec; 67(24):11612-20. PubMed ID: 18089790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
    Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
    Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is miR-144 an effective inhibitor of PTEN mRNA: a controversy in breast cancer.
    Kia V; Sharif Beigli M; Hosseini V; Koochaki A; Paryan M; Mohammadi-Yeganeh S
    In Vitro Cell Dev Biol Anim; 2018 Oct; 54(9):621-628. PubMed ID: 30132256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
    Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
    Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
    Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.